Use of the blood substitute HBOC‐201 in critically ill patients during sickle crisis: a three‐case series

BACKGROUND Red blood cell (RBC) transfusion is an important treatment modality during severe sickle cell crisis (SCC). SCC patients who refuse, or cannot accept, RBCs present a unique challenge. Acellular hemoglobin (Hb)‐based oxygen carriers (HBOCs) might be an alternative for critically ill patien...

Full description

Bibliographic Details

Published in:	Transfusion (Philadelphia, Pa.) Vol. 58; no. 1; pp. 132 - 137
Main Authors:	Davis, Jonathan M., El‐Haj, Nura, Shah, Nimish N., Schwartz, Garry, Block, Margaret, Wall, James, Tidswell, Mark, DiNino, Ernest
Format:	Journal Article
Language:	English
Published:	United States Wiley Subscription Services, Inc 01-01-2018
Subjects:	Anemia Blood substitutes Blood transfusion Bridge failure Clinical trials Erythrocytes Hemoglobin Medical research Oxygen Patients Sickle cell disease Transfusion
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!